Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage (Q38166813)

30 August 2017

title

Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage (English)

1 reference

30 August 2017

Hoyee Wan

1

1 reference

30 August 2017

Bader Murshed AlHarbi

series ordinal

2

1 reference

30 August 2017

Robert Loughlin Macdonald

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

27 November 2013

1 reference

Expert Opinion on Pharmacotherapy

30 August 2017

published in

1 reference

30 August 2017

volume

15

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

231-243

1 reference

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Management of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Subarachnoid hemorrhage and inflammation: bench to bedside and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Thresholds of focal cerebral ischemia in awake monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Glutamate release and neuronal damage in ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

A review of hemoglobin and the pathogenesis of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Relationship between angiographic vasospasm and regional hypoperfusion in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Direct observation of the human cerebral microcirculation during aneurysm surgery reveals increased arteriolar contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Abnormal responses of the human cerebral microcirculation to papaverin during aneurysm surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Cerebral microthrombosis in symptomatic cerebral vasospasm--a quantitative histological study in autopsy cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Longitudinal depolarization gradients along the somatodendritic axis of CA1 pyramidal cells: a novel feature of spreading depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Pathophysiology of the migraine aura. The spreading depression theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Ion changes in spreading ischaemia induce rat middle cerebral artery constriction in the absence of NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Endogenous antioxidants and radical scavengers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Free radical-induced damage to DNA: mechanisms and measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Mechanisms of free radical oxidation of unsaturated lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Bidirectional relation between inflammation and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Neutralization of interleukin-1beta reduces vasospasm and alters cerebral blood vessel density following experimental subarachnoid hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

TNF-R1 signaling: a beautiful pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Pharmacology of nimodipine. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Cisternal sustained release dihydropyridines for subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Statin inhibition of HMG-CoA reductase: a 3-dimensional view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Statin effects beyond lipid lowering--are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Effects of statins on adhesion molecule expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Association of statins with inflammatory cytokines: a population-based Colaus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Magnesium: Nature's physiologic calcium blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

The mitochondrial permeability transition: the brain's point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Cerebrolysin: a review of its use in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Rho-kinase inhibition enhances axonal regeneration after peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.865724

Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1007/978-3-211-75718-5_28

Identifiers

DOI

10.1517/14656566.2014.865724

1 reference

30 August 2017

1 reference